| UHC Surest Medical and Drug | Saphnelo® (Anifrolumab-Fnia) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Surest Medical and Drug | Scenesse® (Afamelanotide) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Surest Medical and Drug | Spevigo® (Spesolimab-Sbzo) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Surest Medical and Drug | Viltepso® (Viltolarsen) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Surest Medical and Drug | Vyondys 53® (Golodirsen) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| Sunshine Health Clinical Policy | Diaphragmatic/Phrenic Nerve Stimulation | 2025-07-01 |
| Sunshine Health Clinical Policy | Intradiscal Steroid Injections for Pain Management | 2025-07-01 |
| Ambetter Health Florida Clinical | Diaphragmatic/Phrenic Nerve Stimulation | 2025-07-01 |
| Ambetter Health Florida Clinical | Intradiscal Steroid Injections for Pain Management | 2025-07-01 |
| Ambetter Health Florida Clinical | Lantidra (donislecel): Allogeneic Pancreatic Islet Cellular Therapy | 2025-07-01 |